Sunshine Biopharma Inc. (SBFM) stock
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.54−0.06 (-2.31%)
Close on Nov 17, 2026Market cap $9.85MP/E –Yield –
Sunshine Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Sunshine Biopharma's price to book ratio was 0.2× on Nov 11, 2026, against 54.6× a year earlier. Over the last 5 years it ranged from 0.0× to 100.4×, with a median of 1.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −46.1 |
| 2025 | Dec 31, 2025 | 46.3× | −1.6 |
| 2024 | Dec 31, 2024 | 47.9× | +47.3 |
| 2023 | Dec 29, 2023 | 0.6× | +0.0 |
| 2022 | Dec 30, 2022 | 0.6× | +0.6 |
| 2014 | Jan 31, 2014 | 0.0× | +0.0 |
| 2013 | Dec 31, 2013 | 0.0× | +0.0 |
| 2012 | Dec 31, 2012 | 0.0× | +0.0 |
| 2011 | Dec 30, 2011 | 0.0× | – |
See a number that looks wrong?